Cargando…
Majocchi’s granuloma: current perspectives
Majocchi’s granuloma (MG) is a rare fungal infection of the dermis that is mainly caused by dermatophytes (in ≥95% of cases); the most frequently identified cause is anthropophilic Trichophyton rubrum. In the rest of the cases, the causes are non-dermatophytic fungi such as Aspergillus species. This...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968791/ https://www.ncbi.nlm.nih.gov/pubmed/29861637 http://dx.doi.org/10.2147/IDR.S145027 |
_version_ | 1783325844649803776 |
---|---|
author | Boral, Hazal Durdu, Murat Ilkit, Macit |
author_facet | Boral, Hazal Durdu, Murat Ilkit, Macit |
author_sort | Boral, Hazal |
collection | PubMed |
description | Majocchi’s granuloma (MG) is a rare fungal infection of the dermis that is mainly caused by dermatophytes (in ≥95% of cases); the most frequently identified cause is anthropophilic Trichophyton rubrum. In the rest of the cases, the causes are non-dermatophytic fungi such as Aspergillus species. This review aimed to provide information about the current perspectives on MG regarding its clinical characteristics, predisposing factors, laboratory diagnosis, and treatment strategies. Although the lower extremities were reported to be the most common site of infection, facial involvement has been predominant in the past 5 years. Our literature research showed that the most common predisposing factor (55%) is the use of topical steroid creams without potassium hydroxide examination during treatment of erythematous squamous dermatoses. A reliable diagnosis of MG is based on histopathological examination, including fungal culture and molecular analyses. MG should be treated not only with topical agents but also with systemic antifungal agents that are continued until the lesions are completely resolved. In systemic treatment, the most preferred drug is terbinafine, because of its efficacy, side effects, and safety. |
format | Online Article Text |
id | pubmed-5968791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-59687912018-06-01 Majocchi’s granuloma: current perspectives Boral, Hazal Durdu, Murat Ilkit, Macit Infect Drug Resist Review Majocchi’s granuloma (MG) is a rare fungal infection of the dermis that is mainly caused by dermatophytes (in ≥95% of cases); the most frequently identified cause is anthropophilic Trichophyton rubrum. In the rest of the cases, the causes are non-dermatophytic fungi such as Aspergillus species. This review aimed to provide information about the current perspectives on MG regarding its clinical characteristics, predisposing factors, laboratory diagnosis, and treatment strategies. Although the lower extremities were reported to be the most common site of infection, facial involvement has been predominant in the past 5 years. Our literature research showed that the most common predisposing factor (55%) is the use of topical steroid creams without potassium hydroxide examination during treatment of erythematous squamous dermatoses. A reliable diagnosis of MG is based on histopathological examination, including fungal culture and molecular analyses. MG should be treated not only with topical agents but also with systemic antifungal agents that are continued until the lesions are completely resolved. In systemic treatment, the most preferred drug is terbinafine, because of its efficacy, side effects, and safety. Dove Medical Press 2018-05-22 /pmc/articles/PMC5968791/ /pubmed/29861637 http://dx.doi.org/10.2147/IDR.S145027 Text en © 2018 Boral et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Boral, Hazal Durdu, Murat Ilkit, Macit Majocchi’s granuloma: current perspectives |
title | Majocchi’s granuloma: current perspectives |
title_full | Majocchi’s granuloma: current perspectives |
title_fullStr | Majocchi’s granuloma: current perspectives |
title_full_unstemmed | Majocchi’s granuloma: current perspectives |
title_short | Majocchi’s granuloma: current perspectives |
title_sort | majocchi’s granuloma: current perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968791/ https://www.ncbi.nlm.nih.gov/pubmed/29861637 http://dx.doi.org/10.2147/IDR.S145027 |
work_keys_str_mv | AT boralhazal majocchisgranulomacurrentperspectives AT durdumurat majocchisgranulomacurrentperspectives AT ilkitmacit majocchisgranulomacurrentperspectives |